Indication
Essential hypertension
2 clinical trials
6 products
Clinical trial
Efficacy and Safety Evaluation of the New Association on Fixed Dose of Olmesartan + Chlorthalidone, Produced by EMS S.A,in Arterial Hypertension ControlStatus: Not yet recruiting, Estimated PCD: 2026-06-01
Product
Losartan + ChlorthalidoneClinical trial
Confirmatory Study of the Efficacy and Safety of the Combination of Losartan / Chlorthalidone vs Losartan / Hydrochlorothiazide in the Treatment of Patients With Essential Arterial HypertensionStatus: Completed, Estimated PCD: 2023-08-15